These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30425655)

  • 1. Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1.
    Hintze S; Knaier L; Limmer S; Schoser B; Meinke P
    Front Physiol; 2018; 9():1532. PubMed ID: 30425655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts.
    Viegas D; Pereira CD; Martins F; Mateus T; da Cruz E Silva OAB; Herdeiro MT; Rebelo S
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.
    Harmon EB; Harmon ML; Larsen TD; Yang J; Glasford JW; Perryman MB
    J Biol Chem; 2011 Nov; 286(46):40296-306. PubMed ID: 21949239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle.
    Todorow V; Hintze S; Schoser B; Meinke P
    Front Cell Dev Biol; 2022; 10():1007331. PubMed ID: 36699009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTG-Repeat Detection in Primary Human Myoblasts of Myotonic Dystrophy Type 1.
    Hintze S; Mensel R; Knaier L; Schoser B; Meinke P
    Front Neurosci; 2021; 15():686735. PubMed ID: 34262431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1.
    Todorow V; Hintze S; Kerr ARW; Hehr A; Schoser B; Meinke P
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
    Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)
    André LM; van Cruchten RTP; Willemse M; Bezstarosti K; Demmers JAA; van Agtmaal EL; Wansink DG; Wieringa B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.
    Beffy P; Del Carratore R; Masini M; Furling D; Puymirat J; Masiello P; Simili M
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1973-83. PubMed ID: 20797447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice.
    Guiraud-Dogan C; Huguet A; Gomes-Pereira M; Brisson E; Bassez G; Junien C; Gourdon G
    Biochim Biophys Acta; 2007 Dec; 1772(11-12):1183-91. PubMed ID: 17950578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of myotonic dystrophy type 1].
    Magaña JJ; Leyva-García N; Cisneros B
    Gac Med Mex; 2009; 145(4):331-7. PubMed ID: 20073433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients.
    Provenzano C; Cappella M; Valaperta R; Cardani R; Meola G; Martelli F; Cardinali B; Falcone G
    Mol Ther Nucleic Acids; 2017 Dec; 9():337-348. PubMed ID: 29246312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.
    Fernandez-Costa JM; Garcia-Lopez A; Zuñiga S; Fernandez-Pedrosa V; Felipo-Benavent A; Mata M; Jaka O; Aiastui A; Hernandez-Torres F; Aguado B; Perez-Alonso M; Vilchez JJ; Lopez de Munain A; Artero RD
    Hum Mol Genet; 2013 Feb; 22(4):704-16. PubMed ID: 23139243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.